Pulse Biosciences (PLSE) Change in Accured Expenses (2015 - 2025)

Pulse Biosciences' Change in Accured Expenses history runs 11 years deep, the most recent figure standing at -$1.6 million for Q4 2025.

• In Q4 2025, Change in Accured Expenses fell 150.76% year-over-year to -$1.6 million; the TTM figure through Dec 2025 stood at -$3.4 million (down 207.41% YoY), while the FY2025 annual figure was -$3.4 million, down 207.41% from the prior year.
• Change in Accured Expenses for Q4 2025 stood at -$1.6 million, down from $427000.0 in the prior quarter.
• The five-year high for Change in Accured Expenses was $3.2 million in Q4 2024, with the low at -$3.0 million in Q1 2025.
• The 5-year median for Change in Accured Expenses is $314500.0 (2021), against an average of -$8611.1.
• The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses surged 49500.0% in 2023, then plunged 411.69% in 2024.
• Pulse Biosciences' Change in Accured Expenses stood at $636000.0 in 2021, then plunged by 382.23% to -$1.8 million in 2022, then soared by 145.13% to $810000.0 in 2023, then jumped by 295.68% to $3.2 million in 2024, then sank by 150.76% to -$1.6 million in 2025.
• Business Quant data shows PLSE's Change in Accured Expenses at -$1.6 million in Q4 2025, $427000.0 in Q3 2025, and $793000.0 in Q2 2025.